nuvaxovid
novavax cz, a.s. - sars cov-2 (original) recombinant spike protein, sars-cov-2 (omicron xbb.1.5) recombinant spike protein - covid-19 virus infection - covid-19 vaccines - nuvaxovid is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 12 years of age and older. Η χρήση αυτού του εμβολίου θα πρέπει να γίνεται σύμφωνα με τις επίσημες συστάσεις. nuvaxovid xbb. 5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 12 years of age and older. Η χρήση αυτού του εμβολίου θα πρέπει να γίνεται σύμφωνα με τις επίσημες συστάσεις.
vidprevtyn beta
sanofi pasteur - sars-cov-2 prefusion spike delta tm protein, recombinant (b.1.351 strain) - covid-19 virus infection - Εμβόλια - vidprevtyn beta is indicated as a booster for active immunisation to prevent covid-19 in adults who have previously received an mrna or adenoviral vector covid-19 vaccine (see sections 4. 2 και 5. 1 in product information document). Η χρήση αυτού του εμβολίου θα πρέπει να γίνεται σύμφωνα με τις επίσημες συστάσεις.
bimervax
hipra human health s.l. - sars-cov-2 virus recombinant spike (s) protein receptor binding domain (rbd) fusion heterodimer – b.1.351-b.1.1.7 strains - covid-19 virus infection - Εμβόλια - bimervax is indicated as a booster for active immunisation to prevent covid-19 in individuals 16 years of age and older who have previously received a mrna covid-19 vaccine.
alpheon
biopartners gmbh - recombinant human interferon alfa-2a - Ηπατίτιδα c, Χρόνια - Ανοσοδιεγερτικά, - adult patients with histologically proven chronic hepatitis c who are positive for hepatitis c virus (hcv) antibodies or hcv rna and have elevated serum alanine aminotransferase (alt) without liver decompensation. the efficacy of interferon alfa-2a in the treatment of hepatitis c is enhanced when combined with ribavirin. alpheon should be given alone mainly in case of intolerance or contra-indication to ribavirin.
recombinate 1000iu with 10ml solvent powder & solvent for solution for injection
baxalta innovations gmbh (0000010056) industriestrasse 67, vienna, a-1221 - factor viii (antihaemofilic factor) - powder & solvent for solution for injection - 1000iu with 10ml solvent - factor viii (antihaemofilic factor) (0009001278) 500iu - coagulation factor viii
recombinate 500iu with 10ml solvent powder & solvent for solution for injection
baxalta innovations gmbh (0000010056) industriestrasse 67, vienna, a-1221 - factor viii (antihaemofilic factor) - powder & solvent for solution for injection - 500iu with 10ml solvent - factor viii (antihaemofilic factor) (0009001278) 500iu - coagulation factor viii
recombinate 250iu with 10ml solvent powder & solvent for solution for injection
baxalta innovations gmbh (0000010056) industriestrasse 67, vienna, a-1221 - factor viii (antihaemofilic factor) - powder & solvent for solution for injection - 250iu with 10ml solvent - factor viii (antihaemofilic factor) (0009001278) 250iu - coagulation factor viii
genotropin 32iu/ml(36.8iu/vial) ly.pd.inj
kabi pharmacia a.e. - somatropin human, recombinant - ΕΝΕΣΙΜΟ ΛΥΟΦΙΛΟ - 32iu/ml(36.8iu/vial) - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ
genotropin kabivial 32iu/ml(36.8iu/vial) ly.pd.inj
kabi pharmacia a.e. - somatropin human, recombinant - ΕΝΕΣΙΜΟ ΛΥΟΦΙΛΟ - 32iu/ml(36.8iu/vial) - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ
norditropin 12 iu/cartridge ly.pd.inj
novo nordisk hellas ltd - somatropin human, recombinant - ΕΝΕΣΙΜΟ ΛΥΟΦΙΛΟ - 12 iu/cartridge